seminar edible_vaccines 2

26
Edible Vaccines Prepared by: Rubielyn Narra

Upload: rubielyn-narra

Post on 06-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 1/26

Edible Vaccines

Prepared by:

Rubielyn Narra

Page 2: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 2/26

Plants as Bioreactors

Transgenic non-food GM

plant pharming;biopharming;

molecular farming;

or simply, pharming

Page 3: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 3/26

MOLECULAR FARMING

Molecular farming is a method used tointegrate a foreign gene into plants.

Molecular farming is the term for newuse plants only (not animals) and isdifferent in that this does not affect andhas nothing to do with food.

Page 4: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 4/26

Plants genetically engineeredto make products that are notof plant origin

Products: therapeutics,vaccines, antibodies,industrial proteins, bioplastics

Pro’s: large amounts, no

bacterial or viralcontamination, low productioncost

Con’s: different sugar 

residuesThere are two types ofMolecular Farming: Medicaland non-Medical.

Page 5: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 5/26

Medical Molecular Farming

The first synthesis of a pharmaceutically-relevant protein, human growth hormone,was described in transgenic tobacco

plants in 1986.

Now, molecular farming has becomecommercially interesting as a method for

the production of recombinantpharmaceutical proteins, in particularantibodies.

Page 6: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 6/26

Non-Medical Molecular Farming 

Non-Medical Molecular Farming includesIndustrial Enzymes and Polymers.• Industrial enzymes: for example laccase in

transgenic maize,

• Technical proteins for research purposes:for example avidin, which is also producedin maize,

• Milk proteins such as human beta casein,

which is produced in transgenic tomatoes,• Protein polymers: collagens, which are

used for medical as well as industrialpurposes.

Page 7: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 7/26

• Potentially the biggest development in this fieldcould be the development of plants growing

biodegradable plastics.

• Other uses could be as

Industrial oils such as hydraulic oil or highyielding biodiesels,

new solid Biofuels,

new Fibers and Papers, and

as agents for Bioremediation andPhytoremediation, environmentally cleaning upcontamination.

Page 8: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 8/26

Molecular Farming

Page 9: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 9/26

Key processes

Transform

Express

Patenting

Page 10: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 10/26

WHY PLANTS?Plants are also very flexible and canproduce a wide variety of proteins.Crop plants can synthesize a wide varietyof proteins that are free of mammalian

toxins and pathogens.Crop plants produce large amounts ofbiomass at low cost and require limitedfacilities.Crops are therefore well suited for theproduction of safe low-cost therapeuticproteins.

Page 11: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 11/26

Edible VaccinesBiotech Plants Serving Human Health Needs

• Works like any vaccine• A transgenic plant with a pathogen protein gene is developed• Potato, banana, and tomato are targets• Humans eat the plant

• The body produces antibodies against pathogen protein• Humans are “immunized” against the pathogen • Examples:

RabiesNorwalk virus (cold virus)Anthrax

Page 12: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 12/26

Rabies Virus Vaccine

Rabies is fatal in 100% of cases when no treatment is givenresulting in 60,000 deaths every year worldwide.

A specific protein of rabies virus, known as G protein, is themajor antigen that causes immunity.

Gene that codes for the G protein was significantly modifiedto facilitate a higher expression of the protein in plants.

Agrobacterium tumefaciens  was used to insert the genethat encodes for the antigen as well as a gene that encodesfor herbicide resistance.

Page 13: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 13/26

Rabies Virus Vaccine

The effect to which the plantvaccine was able to invoke animmune response wasperformed by injecting micewith the protein derived from

tobacco.

The plant made vaccineproduced a higher level ofantibodies for the rabies virusthan the commerciallyavailable rabies vaccine.

Mice from each group werethen challenged with 10LD

50 

of rabies virus. 

(Adapted from Ashraf S, Singh PK, Yadav DK, Shahnawaz M,Mishra S, Sawant SV, Tuli R: High level expression of surfaceglycoprotein of rabies virus in tobacco leaves and itsimmunoprotective activity in mice. Journal of Biotechnology 

2005, 119:1-14.)

Page 14: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 14/26

RABIES VIRUS G PROTEIN IN TOMATO • Gene introduced to tomatoplants by Agrobacterium-  mediated transformation

• Expression of recombinant

glycoprotein in leaves andfruits

• Protein localized in golgibodies, vesicles and

plasmalemma

Page 15: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 15/26

Norwalk virus (cold virus) capsid protein inpotato and tobacco 

• Causative agent for acute epidemicgastroenteritis

•Transformation by Agrobacterium 

• Expression level:

0.37% in potato tubers

0.23% in tobacco leaves

Page 16: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 16/26

Anthrax Vaccine

The toxins PA, LF, and EF are responsible for the pathogenicityof deadly strains of Bacillus anthracis .

The PA gene was expressed in Nicotiana tabacum throughchloroplast transformation

~14% in leaves was PA, 1 acre of land=360 million doses of anthraxvaccine.

Producing proteins in chloroplasts has several advantages:

 – ~10,000 copies of chloroplast DNA in every cell, 10 –25 timeshigher protein levels

 – lack of gene silencing.

 – reduces the risk of a transgene proliferating throughout the

environment

Page 17: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 17/26

Anthrax Vaccine in Transgenic Tomatoes are in early

stage of development.

Page 18: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 18/26

Tomato Callus Differentiating On Selection

Medium

Page 19: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 19/26

Putative Transgenic Tomato Plants at

Bottle Stage

Page 20: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 20/26

Putative Tomato Transgenic PlantsTransferred To Pots

Page 21: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 21/26

Comparison to other VaccineProductions Methods 

Transgenic plants are significantly less expensive thanother means of vaccine production.

~80% of the total production costs are attributed to

extraction and purification of the recombinant proteins – Costs can be reduced by expressing the protein inwatery tissues.

Transgenic cereal crops can be stored at room

temperature.

Plants also provide a greater degree of safety.

Page 22: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 22/26

Comparison to other VaccineProductions Methods 

Table 1Comparison of currently used vectors for recombinant proteinproduction

(Adapted from Balen B, Krsnik-Rasol M, Lt: N-glycosylation of recombinant therapeuticglycoproteins in plant systems. Food Technology and Biotechnology 2007, 45:1-10.)

Page 23: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 23/26

Oral delivery

Edible vaccines would make massimmunization possible at extremely lowcosts.

Concern that the expressed antigenscould be broken down by proteases upon

entering the stomach.

Possible side effects of accidental

consumption of antigen containing plants.

Page 24: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 24/26

Oral delivery

Transgenic rice has been shown to orally immunizeagainst cholera toxin even after prolonged storage.

Mice born to females that had eaten transgenicalfalfa containing an antigen for a class of rotavirusgained partial passive immunity.

A protein necessary for the production of HIV viruswas produced in transgenic tomato plants andelicited the production of antibodies in mice.

Page 25: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 25/26

Conclusion

Plant made vaccines are safe, cheap, effective, andhighly accessible alternative to current methods ofvaccine production.

An array of pathogens, plant species, and transformationtechnology can be used to produce vaccines in plants.

The technology has shown to have numerousadvantages over current methods of vaccine productionas well as a few disadvantages.

Page 26: SEMINAR Edible_vaccines 2

8/2/2019 SEMINAR Edible_vaccines 2

http://slidepdf.com/reader/full/seminar-ediblevaccines-2 26/26

Thank you.